LPL Financial LLC Has $1.16 Million Stock Position in The Chemours Company (NYSE:CC)

LPL Financial LLC grew its stake in shares of The Chemours Company (NYSE:CC) by 11.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,797 shares of the specialty chemicals company’s stock after acquiring an additional 6,937 shares during the period. LPL Financial LLC’s holdings in Chemours were worth $1,163,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its stake in Chemours by 99.7% in the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after buying an additional 765 shares in the last quarter. KBC Group NV lifted its stake in shares of Chemours by 38.2% in the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock valued at $104,000 after purchasing an additional 1,708 shares during the period. EMC Capital Management grew its position in shares of Chemours by 74.6% during the 4th quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company’s stock worth $161,000 after buying an additional 4,073 shares during the period. Matrix Trust Co boosted its position in shares of Chemours by 715.7% during the 4th quarter. Matrix Trust Co now owns 9,952 shares of the specialty chemicals company’s stock worth $168,000 after purchasing an additional 8,732 shares in the last quarter. Finally, Larson Financial Group LLC acquired a new position in shares of Chemours during the fourth quarter worth approximately $205,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Price Performance

CC stock opened at $11.37 on Friday. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The firm has a 50 day moving average price of $13.83 and a 200-day moving average price of $17.31. The Chemours Company has a 52-week low of $9.33 and a 52-week high of $29.21. The firm has a market capitalization of $1.70 billion, a price-to-earnings ratio of 19.94 and a beta of 1.84.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The business had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Equities research analysts forecast that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.80%. The ex-dividend date of this dividend was Friday, February 28th. Chemours’s payout ratio is 175.44%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CC. Barclays lowered their price target on Chemours from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 1st. The Goldman Sachs Group dropped their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Mizuho set a $15.00 price target on shares of Chemours in a report on Tuesday. Morgan Stanley lowered their price objective on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. Finally, Truist Financial dropped their target price on Chemours from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, April 14th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Chemours has an average rating of “Moderate Buy” and an average target price of $21.56.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.